NeuroMetrix, Inc. NASDAQ:NURO

Founder-led company

NeuroMetrix stock price today

$4.58
+0.64
+16.24%
Financial Health
0
1
2
3
4
5
6
7
8
9

NeuroMetrix stock price monthly change

+6.49%
month

NeuroMetrix stock price quarterly change

+6.49%
quarter

NeuroMetrix stock price yearly change

+3.96%
year

NeuroMetrix key metrics

Market Cap
7.88M
Enterprise value
N/A
P/E
-2.33
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
1.38
Price/Book
0.48
PEG ratio
0.02
EPS
-5.97
Revenue
5.27M
EBITDA
-8.64M
Income
-7.98M
Revenue Q/Q
-36.59%
Revenue Y/Y
-31.36%
Profit margin
-53.5%
Oper. margin
-57.43%
Gross margin
69.65%
EBIT margin
-57.43%
EBITDA margin
-164.05%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

NeuroMetrix stock price history

NeuroMetrix stock forecast

NeuroMetrix financial statements

NeuroMetrix, Inc. (NASDAQ:NURO): Profit margin
Jun 2023 1.65M -1.53M -92.83%
Sep 2023 1.20M -1.76M -147.01%
Dec 2023 1.31M -1.64M -125.18%
Mar 2024 1.09M -3.02M -277.04%
NeuroMetrix, Inc. (NASDAQ:NURO): Debt to assets
Jun 2023 22773503 1.36M 5.98%
Sep 2023 21286772 1.38M 6.5%
Dec 2023 21424441 1.33M 6.22%
Mar 2024 20664128 1.90M 9.23%
NeuroMetrix, Inc. (NASDAQ:NURO): Cash Flow
Jun 2023 -1.45M 237.27K 700.12K
Sep 2023 -2.06M 1.65M 1.42K
Dec 2023 -1.45M 97.99K 1.62M
Mar 2024 -2.08M 138.28K 1.47M

NeuroMetrix alternative data

NeuroMetrix, Inc. (NASDAQ:NURO): Employee count
Aug 2023 27
Sep 2023 27
Oct 2023 27
Nov 2023 27
Dec 2023 27
Jan 2024 27
Feb 2024 27
Mar 2024 26
Apr 2024 26
May 2024 26
Jun 2024 26
Jul 2024 26

NeuroMetrix other data

1.31% -6.46%
of NURO is owned by hedge funds
93.62K -452.43K
shares is hold by hedge funds

NeuroMetrix, Inc. (NASDAQ:NURO): Insider trades (number of shares)
Period Buy Sel
Apr 2024 0 1000
Transaction Date Insider Security Shares Price per share Total value Source
Option
HIGGINS THOMAS T officer: Senior Vice President,..
Common Stock 498 $4.47 $2,226
Option
HIGGINS THOMAS T officer: Senior Vice President,..
Restricted Stock Unit 498 $4.47 $2,226
Option
GOZANI SHAI director, officer.. Common Stock 636 $4.47 $2,843
Option
GOZANI SHAI director, officer.. Restricted Stock Unit 636 $4.47 $2,843
Option
FLUEGEL BRADLEY M director
Common Stock 5,396 $4.37 $23,581
Option
FLUEGEL BRADLEY M director
Restricted Stock Unit 5,396 $4.37 $23,581
Option
VAN AVERMAETE DAVID director
Common Stock 5,396 $4.37 $23,581
Option
VAN AVERMAETE DAVID director
Restricted Stock Unit 5,396 $4.37 $23,581
Option
GOODMAN DAVID director Common Stock 5,396 $4.37 $23,581
Option
GOODMAN DAVID director Restricted Stock Unit 5,396 $4.37 $23,581
Patent
Application
Filling date: 1 Feb 2022 Issue date: 21 Jul 2022
Grant
Filling date: 1 Sep 2020 Issue date: 19 Jul 2022
Grant
Filling date: 15 Aug 2017 Issue date: 1 Mar 2022
Grant
Filling date: 2 Jul 2019 Issue date: 15 Feb 2022
Grant
Filling date: 7 May 2019 Issue date: 15 Feb 2022
Grant
Filling date: 22 Dec 2017 Issue date: 1 Feb 2022
Application
Filling date: 13 Jul 2021 Issue date: 6 Jan 2022
Grant
Filling date: 24 Dec 2018 Issue date: 7 Dec 2021
Application
Filling date: 9 Mar 2021 Issue date: 26 Aug 2021
Grant
Filling date: 29 May 2018 Issue date: 13 Jul 2021
Wednesday, 18 December 2024
prnewswire.com
Tuesday, 17 December 2024
businesswire.com
globenewswire.com
globenewswire.com
Wednesday, 6 November 2024
zacks.com
Tuesday, 13 August 2024
globenewswire.com
Saturday, 10 August 2024
seekingalpha.com
Wednesday, 31 July 2024
globenewswire.com
Monday, 20 May 2024
https://www.defenseworld.net
Wednesday, 15 May 2024
globenewswire.com
Friday, 19 April 2024
globenewswire.com
Thursday, 14 March 2024
globenewswire.com
Wednesday, 13 March 2024
globenewswire.com
Tuesday, 12 March 2024
accesswire.com
Monday, 4 March 2024
accesswire.com
Thursday, 22 February 2024
Seeking Alpha
Thursday, 15 February 2024
GlobeNewsWire
Monday, 8 January 2024
GlobeNewsWire
Thursday, 28 September 2023
GlobeNewsWire
Wednesday, 30 August 2023
GlobeNewsWire
Thursday, 20 July 2023
GlobeNewsWire
Wednesday, 3 May 2023
Seeking Alpha
Friday, 28 April 2023
GlobeNewsWire
Thursday, 23 February 2023
Seeking Alpha
Thursday, 16 February 2023
GlobeNewsWire
Thursday, 20 October 2022
Seeking Alpha
Wednesday, 12 October 2022
GlobeNewsWire
Friday, 23 September 2022
Seeking Alpha
Thursday, 21 July 2022
Seeking Alpha
Thursday, 14 July 2022
GlobeNewsWire
  • What's the price of NeuroMetrix stock today?

    One share of NeuroMetrix stock can currently be purchased for approximately $4.58.

  • When is NeuroMetrix's next earnings date?

    Unfortunately, NeuroMetrix's (NURO) next earnings date is currently unknown.

  • Does NeuroMetrix pay dividends?

    No, NeuroMetrix does not pay dividends.

  • How much money does NeuroMetrix make?

    NeuroMetrix has a market capitalization of 7.88M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 28.52% to 5.9M US dollars.

  • What is NeuroMetrix's stock symbol?

    NeuroMetrix, Inc. is traded on the NASDAQ under the ticker symbol "NURO".

  • What is NeuroMetrix's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of NeuroMetrix?

    Shares of NeuroMetrix can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are NeuroMetrix's key executives?

    NeuroMetrix's management team includes the following people:

    • Mr. Thomas T. Higgins Senior Vice President, Chief Financial Officer & Treasurer(age: 73, pay: $150,000)
    • Dr. Shai N. Gozani Founder, Chairman, Chief Executive Officer, Pres & Sec.(age: 60, pay: $35,780)
  • Is NeuroMetrix founder-led company?

    Yes, NeuroMetrix is a company led by its founder Dr. Shai N. Gozani.

  • How many employees does NeuroMetrix have?

    As Jul 2024, NeuroMetrix employs 26 workers.

  • When NeuroMetrix went public?

    NeuroMetrix, Inc. is publicly traded company for more then 21 years since IPO on 22 Jul 2004.

  • What is NeuroMetrix's official website?

    The official website for NeuroMetrix is neurometrix.com.

  • Where are NeuroMetrix's headquarters?

    NeuroMetrix is headquartered at 4B Gill Street, Woburn, MA.

  • How can i contact NeuroMetrix?

    NeuroMetrix's mailing address is 4B Gill Street, Woburn, MA and company can be reached via phone at +7 818909989.

NeuroMetrix company profile:

NeuroMetrix, Inc.

neurometrix.com
Exchange:

NASDAQ

Full time employees:

26

Industry:

Medical - Devices

Sector:

Healthcare

NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.

4B Gill Street
Woburn, MA 01801

CIK: 0001289850
ISIN: US6412558800
CUSIP: 641255807